Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxelidine fumarate vs sufentanil for sedation in elderly patients undergoing painless gastroenteroscopy
ChiCTR2400091617Phase 4Not yet recruiting
- Sponsor
- Shunde Hospital of Guangzhou University of Chinese Medicine
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in procedural pain and anxiety disorder (2 arms), sponsored by Shunde Hospital of Guangzhou University of Chinese Medicine. Primary endpoints: Incidence of hypotension, Incidence of respiratory depression and 1 more. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
procedural painanxiety disorder
Beyond the preview
Go deeper on ChiCTR2400091617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091617.